当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析 - 现金流量表

济川药业

(600566)

  

流通市值:241.09亿  总市值:241.91亿
流通股本:9.18亿   总股本:9.21亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,113,363,265.263,854,281,141.732,611,542,085.079,285,378,818.03
  收到其他与经营活动有关的现金165,223,549.12135,361,470.7471,043,393.42435,640,673.19
  经营活动现金流入小计5,278,586,814.383,989,642,612.472,682,585,478.499,721,019,491.22
  购买商品、接受劳务支付的现金1,042,326,910.81561,222,142.9339,966,490.961,593,300,842.31
  支付给职工以及为职工支付的现金635,208,241.16463,971,131.07294,245,281.18939,022,420.77
  支付的各项税费765,960,005.08551,348,816.71373,521,198.511,463,955,858.95
  支付其他与经营活动有关的现金2,131,580,287.931,440,626,170.46880,948,032.063,548,303,353.41
  经营活动现金流出小计4,575,075,444.983,017,168,261.141,888,681,002.717,544,582,475.44
  经营活动产生的现金流量净额703,511,369.4972,474,351.33793,904,475.782,176,437,015.78
二、投资活动产生的现金流量:
  收回投资收到的现金4,301,455,497.243,134,707,317.39889,000,0005,033,913,092.01
  取得投资收益收到的现金157,179,525.62131,964,543.7728,821,989.6584,811,095.91
  处置固定资产、无形资产和其他长期资产收回的现金净额129,452.08110,572.3330,242.33694,758.08
  投资活动现金流入小计4,458,764,474.943,266,782,433.49917,852,231.985,119,418,946
  购建固定资产、无形资产和其他长期资产支付的现金71,945,552.1840,820,725.8625,549,337.56174,335,473.35
  投资支付的现金4,949,584,600.054,202,000,000901,500,0006,985,000,000
  投资活动现金流出小计5,021,530,152.234,242,820,725.86927,049,337.567,159,335,473.35
  投资活动产生的现金流量净额-562,765,677.29-976,038,292.37-9,197,105.58-2,039,916,527.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,500,0002,500,000--
  取得借款收到的现金761,158,197.31446,605,850.68283,631,958.411,441,663,600.75
  筹资活动现金流入小计763,658,197.31449,105,850.68283,631,958.411,441,663,600.75
  偿还债务支付的现金495,019,590.12425,933,702.11317,438,067.991,405,555,915.49
  分配股利、利润或偿付利息支付的现金1,917,334,555.031,914,503,767.513,581,684.11,217,666,108.8
  支付其他与筹资活动有关的现金31,514,184.4828,050,684.481,561,418.8423,582,131.26
  筹资活动现金流出小计2,443,868,329.632,368,488,154.1322,581,170.932,646,804,155.55
  筹资活动产生的现金流量净额-1,680,210,132.32-1,919,382,303.42-38,949,212.52-1,205,140,554.8
四、汇率变动对现金及现金等价物的影响-103.35--
五、现金及现金等价物净增加额-1,539,464,440.21-1,922,946,141.11745,758,157.68-1,068,620,066.37
  加:期初现金及现金等价物余额6,669,362,743.716,669,362,743.716,669,362,743.717,737,982,810.08
  期末现金及现金等价物余额5,129,898,303.54,746,416,602.67,415,120,901.396,669,362,743.71
补充资料:
  净利润-725,285,908.9-2,536,706,331.49
  资产减值准备-1,140,852.47-2,881,730.82
  固定资产和投资性房地产折旧-139,719,766.85-278,867,314.01
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-139,719,766.85-278,867,314.01
  无形资产摊销-17,281,734.47-27,831,205.49
  长期待摊费用摊销-200,789.76-1,221,795.3
  处置固定资产、无形资产和其他长期资产的损失--68,411.54--197,641.88
  固定资产报废损失-371,876.24-281,712.99
  公允价值变动损失-32,509,512.31--99,202,006.27
  财务费用-7,057,473.19-27,273,290.37
  投资损失--131,621,780.6--83,540,174.24
  递延所得税-11,413,732.06-22,172,478.51
  其中:递延所得税资产减少-7,402,082.47-3,612,933.12
    递延所得税负债增加-4,011,649.59-18,559,545.39
  存货的减少-229,396,727.65--81,895,122.84
  经营性应收项目的减少-266,960,351.91-253,555,395.35
  经营性应付项目的增加--308,663,774.61--698,675,991.1
  其他-1,779,663.44-10,090,892.02
  现金的期末余额-4,746,416,602.6-6,669,362,743.71
  减:现金的期初余额-6,669,362,743.71-7,737,982,810.08
  现金及现金等价物的净增加额--1,922,946,141.11--1,068,620,066.37
公告日期2025-10-282025-08-232025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑